Virbac stock slips as Virbac keeps guidance and eyes September 17

Published on 09/08/2026 at 16:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Virbac stock trades softer in Paris as the French animal health group keeps its 2026 guidance and heads toward half-year results on September 17, 2026.

Schwarzweißes Reportagefoto eines Veterinärlabors mit Forschern bei der Arbeit — Dokumentarische Schwarzweiß-Reportage über Virbac S.A., Aktie FR0000031577, zeigt ein modernes Labor der Tiergesundheitsbranche, Illustration mit AI erstellt.

Virbac stock (FR0000031577) changed hands at EUR 314.50 on Euronext Paris on September 7, 2026, after a 1.57 percent daily decline and a 2.94 percent drop for the year, according to Boursorama. The same market snapshot shows the shares below the 52-week backdrop investors have been watching into the September 8, 2026 session.

Guidance stays in view

MarketScreener notes that Virbac had already reported first-quarter 2026 revenue of EUR 384 million and confirmed its 2026 guidance. That makes the next scheduled half-year update on September 17, 2026, the key near-term date for the stock.

For investors, the number that matters is the combination of EUR 384 million in first-quarter sales and the confirmed 2026 outlook, because it keeps attention on whether growth remains intact into the second half of the year.

Consensus still leans higher

MarketScreener also cites Stifel's view from March 19, 2026, with a EUR 440 price target for Virbac. Against the EUR 314.50 market level, that target implies a gap of EUR 125.50, or 39.9 percent.

The spread is large enough to matter, but it now sits beside the stock's year-to-date decline of 2.94 percent, which leaves the shares well behind the target call as the half-year report approaches.

Animal health remains the core

Virbac builds its business around animal health products for pets and farm animals, so the half-year update will again be read through sales growth and margin development rather than headline market noise. The company's own investor page points readers to the regulated half-year reporting cycle, which is why September 17, 2026 is the next important reference point for the product mix and profitability story.

Price and next step

Virbac stock closed at EUR 314.50 on September 7, 2026, on Euronext Paris. The September 17, 2026 half-year release will determine whether the current discount to the EUR 440 target narrows or widens.